Western blot (N = 7, P < 0.001) and immunohistochemistry (N = 10, P < 0.001) confirmed that SCNN1B is significantly downregulated in CRC compared to their corresponding adjacent normal tissues (Fig. 1D). This evidence concerns the gene SCNN1B and colorectal carcinoma.